Under anti–PD-1/PD-L1, CD8 proliferation could be enhanced through direct blockade of PD-1 on CD8 T cells and through reinvigoration of the helper activity of tumor Ag–specific CD4 T cells. This evidence concerns the gene CD8A and neoplasm.